How Has The Biosurgery Market Size Evolved In Recent Years?
The biosurgery market has seen considerable growth due to a variety of factors.
• The expansion of the biosurgery market has been robust in the past few years. The sector is projected to escalate from $15.27 billion in 2024 to $16.49 billion in 2025, with a compound annual growth rate (CAGR) of 8.0%. The historical growth can be traced back to factors such as heightened surgical procedures, increase in chronic illnesses, ageing population, shift to greener products, changes in regulations, and endorsements.
What Are The Predictions for The Biosurgery Market?
The Biosurgery market is expected to maintain its strong growth trajectory in upcoming years.
• Over the coming years, the biosurgery market is anticipated to experience substantial expansion, with predictions suggesting it will reach a value of $22.98 billion by 2029, growing at a compound annual growth rate (CAGR) of 8.7%.
Contributing factors to this growth during the forecast period include advancements in tissue engineering, the popularity of minimally invasive procedures, the emphasis on regenerative medicine, the shift towards biologics and the needs of an aging population. The forecast period will also potentially see an increase in minimally invasive procedures, a surge in cosmetic and plastic surgeries, a focus on stem cell therapies, progressive wound care, and the development of biodegradable products.
Which Drivers Are Accelerating Growth In The Biosurgery Market?
The growth of the biosurgery market is predicted to be buoyed by the rising prevalence of chronic diseases. Chronic diseases are lasting health concerns that require continuous medical attention and/or inhibit daily pursuits. Diabetes, cancer, and heart disease, conditions viewed as chronic diseases, are the prime causes of death and disability in the United States. Given its ability to remove necrotic tissue, mitigate infection risks, and expedite the healing process for persistent wounds, biosurgery plays a pivotal role in the management of these diseases. As an illustration, in March 2022, the Australian Bureau of Statistics, a standalone legal entity in Australia charged with data gathering and analysis, as well as providing evidence-based advice to all levels of government, revealed that 78.6 percent of Australians were battling at least one chronic disease, equating to 11.6 million people or a majority of the population. As such, the escalating rate of chronic diseases is fueling the expansion of the biosurgery market.
What Are The Core Segments Of The Global Biosurgery Market?
The biosurgery market covered in this report is segmented –
1) By Product: Bone-Graft Substitutes, Soft-Tissue Attachments, Hemostatic Agents, Surgical Sealants And Adhesives, Adhesion Barriers, Staple Line Reinforcement
2) By Source: Natural Or Biologics Products, Synthetic Products
3) By Application: Orthopedic Surgery, General Surgery, Neurological Surgery, Cardiovascular Surgery, Gynecological Surgery, Other Applications
4) By End-User: Hospitals, Clinics, Other End-Users
Subsegments,
1) By Bone-Graft Substitutes: Synthetic Bone Grafts, Natural Bone Grafts
2) By Soft-Tissue Attachments: Mesh Products, Biological Grafts
3) By Hemostatic Agents: Powdered Agents, Gel-based Agents
4) By Surgical Sealants And Adhesives: Fibrin Sealants, Synthetic Sealants
5) By Adhesion Barriers: Absorbable Barriers, Non-absorbable Barriers
6) By Staple Line Reinforcement: Reinforcement Devices, Surgical Staples
Pre-Book The Biosurgery Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Trends Are Reshaping The Biosurgery Market Size?
Leading corporations in the biosurgery industry are capitalizing on technological developments, such as cutting-edge wound care technology, to augment healing results, minimize incidences of infection, and expedite patient healing periods via groundbreaking products and practices. Advanced wound care technology involves novel techniques and goods aimed at improving wound recovery, inhibiting infection, and enhancing patient outcomes. For example, in September 2024, an India-based medical products manufacturing firm, Health Care at Home India Pvt Ltd, rolled out WOW (Warriors of Woundcare) Nurses. This program aims to proactively combat and treat bedsores, a regular complication for mobility-restricted patients. Bedsores can drastically hinder recovery, lengthen hospital admissions, and heighten the risk of infection.
Who Are the Key Players In The Biosurgery Market?
Major companies operating in the biosurgery market include:
• Baxter International Inc.
• B. Braun SE
• Becton
• Dickinson and Company
• Hemostasis LLC
• Integra LifeSciences Corporation
• Johnson & Johnson Services Inc.
• CryoLife Inc.
• CSL Limited
• Pfizer Inc.
• Zimmer Biomet Holdings Inc.
• Kuros Biosciences AG
• Orthofix Medical Inc.
• Smiths & Nephew plc
• Medtronic plc
• Stryker Corp.
• Betatech Medical
• Tissue Regenix Group plc
• Aroa Biosurgery Ltd.
• Anika Therapeutics Inc.
• Arthrex Inc.
• B Braun Surgical SA
• Biom'Up SA
• Boston Scientific Corporation
• Coloplast Corp.
• Cook Medical Inc.
• Endo International plc
• Genzyme Corporation
• Takeda Pharmaceutical Company Limited
• Cerus Corporation
What Are The Regional Insights Into The Biosurgery Market?
North America was the largest region in the biosurgery market in 2024. Asia-Pacific is expected to be the fastest-growing region in the biosurgery market report during the forecast period. The regions covered in the biosurgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
